Why the study?
Does transfemoral TAVI reduce 30-day clinical complications compared to transapical TAVI in patients with aortic stenosis?
Population
6,509 patients with aortic stenosis undergoing transcatheter aortic valve implantation from 20 studies
Comparison
Transfemoral transcatheter aortic valve… vs Transapical transcatheter aortic valve…
Design
Meta-analysis
Follow-up
30 days
Authors
Loading...
Supports preferring transfemoral access when feasible; reinforces meta-analytic evidence for lower early mortality without excess stroke or heart block.
Does transfemoral TAVI reduce 30-day clinical complications compared to transapical TAVI in patients with aortic stenosis?
Transfemoral TAVI is associated with lower 30-day mortality compared to transapical TAVI in patients with aortic stenosis, though rates of stroke and heart block are similar.
Li et al. (2013) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: